Urokinase induces receptor mediated brain tumor cell migration and invasion

Journal of Neuro-Oncology

Volumn 40, Issue 3, 1998, Pages 215-226

  MacDonald, Tobey J ^a   DeClerck, Yves A ^a   Laug, Walter E ^a,b  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b CHILDREN S HOSPITAL LOS ANGELES   (United States)

Author keywords

Brain tumor; Cell migration; Invasion; Urokinase receptor

Indexed keywords

MATRIGEL; MEMBRANE PROTEIN; PHOSPHOLIPASE C; PLASMINOGEN ACTIVATOR; UROKINASE; UROKINASE RECEPTOR;

AMINO TERMINAL SEQUENCE; ARTICLE; ASTROCYTOMA; BRAIN TUMOR; CELL INVASION; CELL MIGRATION; CONTROLLED STUDY; DOSE RESPONSE; ENZYME ACTIVITY; EXTRACELLULAR MATRIX; GLIOBLASTOMA; HUMAN; HUMAN CELL; MEDULLOBLASTOMA; PROTEIN DEGRADATION; PROTEIN EXPRESSION; TUMOR CELL LINE;

BRAIN NEOPLASMS; CELL MOVEMENT; COLLAGEN; DRUG COMBINATIONS; EXTRACELLULAR MATRIX; HUMANS; LAMININ; NEOPLASM INVASIVENESS; PROTEOGLYCANS; RECEPTORS, CELL SURFACE; TUMOR CELLS, CULTURED; URINARY PLASMINOGEN ACTIVATOR;

EID: 0032443742     PISSN: 0167594X     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1006150506789     Document Type: Article

References (41)

1. Quax PH, van Muijen GN, Weening Verhoeff EJ, Lund LR, Dano K, Ruiter DJ, Verheijen JH; Metastatic behavior of human melanoma cell lines in nude mice correlates with urokinase-type plasminogen activator, its type-1 inhibitor, and urokinase-mediated matrix degradation. J Cell Biol 115: 191-199, 1991
2. Mignatti P, Robbing E, Rifkin DB: Tumor invasion through the human amniotic membrane: requirement for a proteinase cascade. Cell 47: 487-498, 1986
3. Dano K, Andreasen PA, Grondahl Hansen J, Kristensen P, Nielsen LS, Skriver L: Plasminogen activators, tissue degradation, and cancer. Adv Cancer Res 44: 139-266, 1985
4. Costantini V, Sidoni A, Deveglia R, Cazzato OA, Bellczza G, Ferri I, Bucciarelli E, Nenci GG: Combined overexpression of urokinase, urokinase receptor, and plasminogen activator inhibitor-1 is associated with breast cancer progression: an immunohistochemical comparison of normal, benign, and malignant breast tissues, Cancer 77: 1079-1088, 1996
5. Pedersen H, Brunner N, Francis D, Osterlind K, Ronne E, Hansen HH, Dano K, Grondahl Hansen J: Prognostic impact of urokinase, urokinase receptor, and type 1 plasminogen activator inhibitor in squamous and large cell lung cancer tissue. Cancer Res 54: 4671-4675, 1994
6. Kohga S, Harvey SR, Weaver RM, Markus G: Localization of plasminogen activators in human colon cancer by immunoperoxidase staining. Cancer Res 45: 1787-1796, 1985
7. Blasi F, Verde P: Urokinase-dependent cell surface proteolysis and cancer. Semin Cancer Biol 1: 117-126, 1990
8. Pollcanen J, Stephens RW, Vaheri A: Directed plasminogen activation at the surface of normal and malignant cells. Adv Cancer Res 57: 273-328, 1991
9. DeClerck YA, Laug WE: The role of the extracellular matrix in tumor invasion, metastasis and angiogenesis. In: Teicher BA (ed) Drug Resistance in Oncology. Marcel Dekker, New York 121-163, 1993
10. Mazzieri R, Masiero L, Zanetta L, Monea S, Onisto M, Garbisa S, Mignatti P: Control of type IV collagenase activity by components of the urokinase-plasmin system; a regulatory mechanism with cell-bound reactants. EMBO J 16: 2319-2332, 1997
11. Wei Y, Waltz DA, Rao N, Drummond RJ, Rosenberg S, Chapman HA: Identification of the urokinase receptor as an adhesion receptor for vitronectin. J Biol Chem 269: 32380-32388, 1994
12. Wei Y, Lukashev M, Simon DI, Bodary SC, Rosenberg S, Doyle MV, Chapman HA: Regulation of integrin function by the urokinase receptor. Science 273: 1551-1555, 1996
13. Nakano A, Tani E, Miyazaki K, Yamamoto Y, Furuyama J: Matrix metalloproteinases and tissue inhibitors of metalloproteinases in human gliomas. J Neurosurg 83; 298-307, 1995
14. Yamamoto M, Sawaya R, Mohanam S, Bindal AK, Bruner JM, Oka K, Rao VH, Tomonaga M, Nicholson GL, Rao JS: Expression and localization of urokinase-type plasminogen activator in human astrocytomas in vivo. Cancer Res 54: 3656-3661, 1994
15. Gladson CL, Pijuan Thompson V, Olman MA, Gillespie GY, Yacoub IZ: Up-regulation of urokinase and urokinase receptor genes in malignant astrocytoma. Am J Pathol 146: 1150-1160, 1995
16. Pollack IF: Brain tumors in children. N Engl J Med 331: 1500-1507, 1994
17. Johnson JH Jr, Phillips PC: Malignant gliomas in children. Cancer Invest 14: 609-621, 1996
18. Mohanam S, Sawaya R, McCutcheon I, Ali Osman F, Boyd D, Rao JS: Modulation of in vitro invasion of human glioblastoma cells by urokinase-type plasminogen activator receptor antibody. Cancer Res 53: 4143-4147, 1993
19. Paulus W, Bauer I, Beutler AS, Reeves SA: Diffuse brain invasion of glioma cells requires beta 1 integrins. Lab Invest 75: 819-826, 1996
20. Laug WE, Cao XR, Yu YB, Shimada H, Kruithof EK: Inhibition of invasion of HT1080 sarcoma cells expressing recombinant plasminogen activator inhibitor 2. Cancer Res 53: 6051-6057, 1993
21. Laug WE, Wang K, Mundi R, Rideout W, Kruithof EK, Bogenmann E: Clonal variation of expression of the genes coding for plasminogen activators, their inhibitors and the urokinase receptor in HT1080 sarcoma cells. Int J Cancer 52: 298-304, 1992
22. Laug WE, Weinblatt ME, Jones P: Endothelial cells degrade extracellular matrix proteins produced in vitro. Thromb Haemost 54: 498-502, 1985
23. Jones PA, DeClerck Y; Destruction of extracellular matrices containing glycoproteins, clastin, and collagen by metastatic human tumor cells. Cancer Res 40; 3222-3227,1980
24. Stahl A, Mucller BM: Binding of urokinase to its receptor promotes migration and invasion of human melanoma cells in vitro. Cancer Res 54: 3066-3067, 1994
25. Repesh L: A new in vitro assay for quantitating tumor cell invasion. Invasion Metastasis 9: 192-208, 1989
26. Shirasuna K, Saka M, Hayashido Y, Yoshioka H, Sugiura T, Matsuya T: Extracellular matrix production and degradation by adenoid cystic carcinoma cells: participation of plasminogen activator and its inhibitor in matrix degradation. Cancer Res 53: 147-152, 1993
27. Gudewicz PW, Gilboa N: Human urokinase-type plasminogen activator stimulates chemotaxis of human neutrophils. Biochem Biophys Res Commun 147: 1176-1181, 1987
28. Busso N, Masur SK, Lazcga D, Waxman S, Ossowski L: Induction of cell migration by pro-urokinase binding to its receptor; possible mechanism for signal transduction in human epithelial cells. J Cell Biol 126: 259-270, 1994
29. Kook YH, Adamski J, Zelent A, Ossowski: The effect of anti-sense inhibition of urokinase receptor in human squamous cell carcinoma on malignancy, EMBO J 13; 3983-3991, 1994
30. Kariko K, Kuo A, Boyd D, Okada SS, Cines DB, Barnathan ES: Overexpression of urokinase receptor increases matrix invasion without altering cell migration in a human oseosarcoma cell line. Cancer Res 53: 3109-3117, 1993
31. Vassalli JD, Baccino D, Belin D: A cellular binding site for the Mr 55,000 form of the human plasminogen activator, urokinase. J Cell Biol 100: 86-92, 1985
32. Ploug M, Bchrendt N, Lobcr D, Dano K: Protein structure and membrane anchorage of the cellular receptor for urokinase-type plasminogen activator. Semin Thromb Hemost 17: 183-193, 1991
33. Crowley CW, Cohen RL, Lucas BK, Liu G, Shuman MA, Levinson AD: Prevention of metastasis by inhibition of the urokinase receptor. Proc Natl Acad Sci USA 90: 5021-5025, 1993
34. Odckon LE, Sato Y, Rifkin DB: Urokinase-type plasminogen mediates basic fibroblast growth factor-induced bovine endothelial cell migration independent of its proteolytic activity. J Cell Physiol 150: 258-263, 1992
35. Waltz DA, Chapman HA: Reversible cellular adhesion to vitronectin linked to urokinase receptor occupancy. J Biol Chem 269: 14746-14750, 1994
36. Bohuslav J, Horejsi V, Hansmann C, Stockl J, Weidle UH, Majdic O, Bartke I, Knapp W, Stockinger H: Urokinase plasminogen activator receptor, beta 2-integrins, and Srckinases within a single receptor complex of human monocytes. J Exp Med 181: 1381-1390, 1995
37. Giese A, Rief MD, Loo MA, Bcrens ME: Determinants of human astrocytoma migration. Cancer Res 54: 3897-3904, 1994
38. Paulus W, Tonn JC; Basement membrane invasion of glioma cells mediated by integrin receptors. J Neurosurg 80: 515-519, 1994
39. Appella E, Robinson EA, Ullrich SJ, Stoppelli MP, Corti A, Cassani G, Blasi F: The receptor-binding sequence of urokinase, A biological function for the growth-factor module of proteases. J Biol Chem 262: 4437-4440, 1987
40. Del Rosso M, Fibbi G, Dini G, Grapponc C, Pucci M, Caldini R, Magnelli L, Fimiani M, Lotti T, Panconesi E: Role of specific membrane receptors in urokinase-dependent migration of human keratinocytes. J Invest Dermatol 94: 310-316, 1990
41. Mohanam S, Chintala SK, Go Y, Bhattacharya A, Venkaiah B, Boyd D, Gokaslan ZL, Sawaya R, Rao JS: In vitro inhibition of human glioblastoma cell line invasiveness by anti-sense uPA receptor. Oncogene 14: 1351-1359, 1997